Introduction to a New SeriesHEPATITIS C: A NEW ERA OF TREATMENT
Here we present an important series dedicated to the new era of HCV treatment.
HEPATITIS C: A NEW ERA OF TREATMENT, SERIES #1Change Has Arrived: Treating Hepatitis C with Protease Inhibitors—the New Standard of Care
Treating patients with the hepatitis C virus (HCV) is about to be changed forever. This article will review the burden of hepatitis C, the HCV lifecycle, and the studies behind the new therapies in an effort to preview how patients will likely be treated in the near future.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #96Nutritional Support for Patients with Acute Kidney Injury: How Much Protein is Enough or Too Much?
Acute kidney injury occurs commonly in critically ill patients and is associated with increased morbidity and mortality in the ICU. In this article, we discuss the metabolic studies available and provide insight into appropriate calorie and protein requirements for critically ill patients with AKI.
A CASE REPORTDiffuse Large B-cell Lymphoma Presenting with Obstructive Jaundice from a Biliary Stricture: A Case Report and Review of Literature
This report describes an unusual case of DLBCL of the pancreas presenting as obstructive jaundice from a biliary stricture.
Crohn's & Colitis Foundation Launches Website Empowering Patients to Better Manage Disease
This website features tools to help patients manage risks and benefits of disease-related decisions. Coping with Crohn's disease and ulcerative colitis - collectively known as inflammatory bowel disease (IBD) - chronic and often debilitating digestive diseases that affect over 1.4 million Americans - is a journey of choices. To help educate patients on the right choices to make for themselves, the Crohn's & Colitis Foundation of America (CCFA), with support from Abbott, has launched a new interactive web site, IBDetermined.org.